The Pharma and Biotech Daily: Stay Informed on the Latest in the Industry

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.President Trump has nominated Susan Monarez as the new head of the CDC, facing challenges such as a measles outbreak that has already resulted in two deaths. Merck commits nearly $2 billion for an oral lipid-lowering drug, joining other companies targeting lipoprotein(a). GSK is studying the impact of their shingles vaccine, Shingrix, on reducing dementia risk. Cassava has ended their Alzheimer's program for Simufilam after years of controversy. The average life sciences salaries have increased by 9% in 2024, but bonuses and equity values have dropped. Trump has doubled down on the threat of tariffs on pharmaceuticals. In other news, Opthea and Unity have failed to unseat Regeneron's Eylea in vision disorders, while Alector will be laying off 13% of its workforce. AstraZeneca is making a potential $10 billion commitment to China despite political pressure. Opportunities in the life sciences industry are available at companies like Oncothera, Dyne Therapeutics, Amgen, and Novo Nordisk.